The Global Hyperparathyroidism Treatment Market is driven by...

The Global Hyperparathyroidism Treatment Market is driven by Increasing Prevalence of Kidney Disease

Posted 2025-03-10 07:32:34

Hyperparathyroidism is a condition in which the parathyroid glands produce excessive amounts of parathyroid hormone (PTH), resulting in high calcium levels in the blood. This excess PTH weakens bones and raises the blood calcium to abnormal levels, which can cause kidney damage and other health issues. Some common symptoms of hyperparathyroidism include fatigue, abdominal pain, nausea, weakness in bones, and frequent kidney stones. Hyperparathyroidism can be caused due to an overactive parathyroid gland or adenoma. The most common treatment for hyperparathyroidism is parathyroidectomy surgery to remove diseased parathyroid glands.

The Global Hyperparathyroidism Treatment Market is estimated to be valued at US$ 3.5 billion in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031.

The increasing incidence and prevalence of chronic kidney disease is a major factor driving the growth of the Hyperparathyroidism Treatment Market. According to the Global Burden of Disease Study, in 2019, around 1.2 million deaths were attributed to chronic kidney disease. With rising cases of diabetes and high blood pressure, the burden of chronic kidney disease is expected to increase substantially in the coming years. This is anticipated to fuel the demand for hyperparathyroidism diagnostics and treatment.

Get More Insights On- Hyperparathyroidism Treatment Market

Get This Report in Japanese Language: 副甲状腺機能亢進症治療市場

Get This Report in Korean Language: 부갑상선기능항진증 치료 시장

Explore More Related Articles: United States Sunflower Seeds is Expecting Strong Growth in Coming Years